Literature DB >> 12886013

Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease.

Dulal Panda1, Jonathan C Samuel, Michelle Massie, Stuart C Feinstein, Leslie Wilson.   

Abstract

The microtubule (MT)-associated protein tau is important in neuronal development and in Alzheimer's and other neurodegenerative diseases. Genetic analyses have established a cause-and-effect relationship between tau dysfunction/misregulation and neuronal cell death and dementia in frontotemporal dementia and parkinsonism associated with chromosome 17; several mutations causing this dementia lead to increased ratios of four-repeat (4R) to three-repeat (3R) wild-type tau, and an attractive hypothesis is that the abnormally high ratio of 4R to 3R tau might lead to neuronal cell death by altering normal tau functions in adult neurons. Thus, we tested whether 3R and 4R tau might differentially modulate the dynamic instability of MTs in vitro using video microscopy. Although both isoforms promoted MT polymerization and decreased the tubulin critical subunit concentration to approximately similar extents, 4R tau stabilized MTs significantly more strongly that 3R tau. For example, 4R tau suppressed the shortening rate, whereas 3R tau had little or no detectable effect. Similarly, 3R tau had no effect on the length shortened during a shortening event, whereas 4R tau strongly reduced this parameter. Further, when MTs were diluted into buffer containing 4R tau, the MTs were stabilized and shortened slowly. In contrast, when diluted into 3R tau, the MTs were unstable and shortened rapidly. Thus, 4R tau stabilizes MTs differently and significantly more strongly than 3R tau. We suggest a "dosage effect" or haploinsufficiency model in which both tau alleles must be active and properly regulated to produce appropriate amounts of each tau isoform to maintain MT dynamics within a tolerable window of activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886013      PMCID: PMC170955          DOI: 10.1073/pnas.1633508100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants.

Authors:  T C Gamblin; M E King; H Dawson; M P Vitek; J Kuret; R W Berry; L I Binder
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

2.  Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau.

Authors:  D Panda; H P Miller; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 3.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

4.  Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.

Authors:  C W Wittmann; M F Wszolek; J M Shulman; P M Salvaterra; J Lewis; M Hutton; M B Feany
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

5.  Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.

Authors:  A Gonçalves; D Braguer; K Kamath; L Martello; C Briand; S Horwitz; L Wilson; M A Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

6.  Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease.

Authors:  B L Goode; M Chau; P E Denis; S C Feinstein
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

7.  Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.

Authors:  M von Bergen; S Barghorn; L Li; A Marx; J Biernat; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

8.  Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

Authors:  B Trinczek; J Biernat; K Baumann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.

Authors:  Bernadette H LaMonte; Karen E Wallace; Beth A Holloway; Spencer S Shelly; Jennifer Ascaño; Mariko Tokito; Thomas Van Winkle; David S Howland; Erika L F Holzbaur
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

10.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors:  K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal:  J Cell Biol       Date:  2002-03-18       Impact factor: 10.539

View more
  97 in total

1.  Tau induces cooperative Taxol binding to microtubules.

Authors:  Jennifer L Ross; Christian D Santangelo; Victoria Makrides; D Kuchnir Fygenson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

2.  E93R substitution of Escherichia coli FtsZ induces bundling of protofilaments, reduces GTPase activity, and impairs bacterial cytokinesis.

Authors:  Richa Jaiswal; Ronak Y Patel; Jayant Asthana; Bhavya Jindal; Petety V Balaji; Dulal Panda
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

3.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 4.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

5.  Tau interconverts between diffusive and stable populations on the microtubule surface in an isoform and lattice specific manner.

Authors:  Derrick P McVicker; Gregory J Hoeprich; Andrew R Thompson; Christopher L Berger
Journal:  Cytoskeleton (Hoboken)       Date:  2014-02-24

Review 6.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

7.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

8.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

9.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

Review 10.  Anesthesia and tau pathology.

Authors:  Robert A Whittington; Alexis Bretteville; Maya F Dickler; Emmanuel Planel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-25       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.